Responsibilities

• Proactively identify and evaluate opportunities within the US diagnostic and wellness markets, including potential B2B partnerships, D2C channels, and new clinical verticals.
• Structure and test business hypotheses. Draft comprehensive business plans and executive-level presentations (PPT) to secure internal buy-in for new strategic initiatives.
• Build and maintain dynamic, multi-year financial models and scenario analyses to support C-suite in forecasting revenue, evaluating unit economics, and assessing the ROI of new initiatives.
• Architect and pilot comprehensive Go-To-Market strategies for new laboratory offerings (e.g., Women's Health, STI/UTI bundles), defining pricing, positioning, and launch timelines.
• Continuously monitor the US diagnostic, telehealth, and Femtech markets. Track competitor pricing, M&A activity, product launches, and regulatory shifts to keep the executive team ahead of market curves.
• Act as the primary strategic liaison between the Gardena-based US operations and the Korean headquarters. Ensure localized US strategies seamlessly align with global corporate objectives and technical capabilities.
• Effectively communicate and manage deliverables across different time zones, displaying high cultural agility and a collaborative, solution-oriented mindset.
• Create and build ad-hoc analyses, including special projects at the request of senior management.